CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- Open-market buys, last 90 days
- $49,118
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,118. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | DO CUONG V President & CEO | Purchase · Warrants (right to buy) | +5,000 | 5,000 | ||
| 2024-02-15 | Palumbo Joseph M Chief Medical Officer | Shares withheld for taxes | −2,476 | $1.18 | $3K | 32,196 |
| 2024-02-15 | KIM JOANNE WENDY Chief Financial Officer | Shares withheld for taxes | −2,476 | $1.18 | $3K | 39,196 |
| 2024-02-15 | DO CUONG V President & CEO | Shares withheld for taxes | −4,953 | $1.18 | $6K | 425,948 |
| 2023-12-11 | KIM JOANNE WENDY Chief Financial Officer | Grant or award | +5,000 | 44,148 | ||
| 2023-12-01 | GORLIN STEVE Director | Sale | −75,680 | $1.69 | $128K | 46,358 |
| 2023-11-30 | DO CUONG V President & CEO | Purchase | +10,000 | $1.78 | $18K | 68,759 |
| 2023-11-09 | Lang James Paul Director | Grant or award · Stock Option (right to buy) | +93,500 | 93,500 | ||
| 2023-11-09 | GORLIN STEVE Director | Grant or award | +46,358 | 122,038 | ||
| 2023-11-09 | ROGICH SIGMUND Director | Grant or award | +42,254 | 42,254 | ||
| 2023-11-09 | Hariri Robert J Director | Grant or award | +42,254 | 42,254 | ||
| 2023-11-09 | Sherman Michael Edward Director | Grant or award · Stock Option (right to buy) | +89,750 | 89,750 | ||
| 2023-11-09 | BERMAN RICHARD J Director | Grant or award | +51,830 | 69,235 | ||
| 2023-09-05 | GORLIN STEVE Director | Sale | −8,560 | $3.05 | $26K | 75,680 |
| 2023-08-22 | BERMAN RICHARD J Director | Sale | −10,805 | $3.50 | $38K | 16,789 |
| 2023-06-29 | DO CUONG V CEO & President | Grant or award | +149,500 | 425,854 | ||
| 2023-06-29 | DO CUONG V CEO & President | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2023-06-21 | DO CUONG V CEO & President | Option exercise | +41,506 | 271,401 | ||
| 2023-06-21 | DO CUONG V CEO & President | Option exercise · Restricted stock units | −41,506 | 83,014 | ||
| 2023-06-07 | KIM JOANNE WENDY Chief Financial Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 3 of 10 · 193 trades